Sermorelin.

Gentle GH-axis support for first-time longevity and body-composition protocols.

Anti-agingBody CompositionSleepRecoverySubcutaneous injection (bedtime preferred)

Build a stack with Sermorelin Buy on catalog

Evidence

What the research shows

Sermorelin is the synthetic GHRH 1–29 fragment and is widely regarded as the gentlest way to stimulate the growth-hormone axis. In current peptide practice, it is positioned for anti-aging and body-composition research specifically because it drives endogenous signaling rather than replacing GH directly. The strongest differentiator here is not a headline weight-loss trial, but its cleaner, more conservative profile for first-time users who want to start with physiologic GH support. Typical research protocols use 100–300 mcg subcutaneously at bedtime on a 5-on/2-off schedule, which aligns with its role in supporting natural nocturnal GH pulsatility. Compared with more aggressive secretagogue stacks, Sermorelin sits at the entry point of the category: simpler, gentler, and easier to tolerate in structured cycles. Interest remains steady because it offers a lower-intensity on-ramp into GH-axis research before moving to more advanced combinations such as CJC-1295/Ipamorelin.

Protocol

Cycle and dosing notes

You start at 100 mcg subcutaneously at bedtime, ideally in a fasted state to align with the natural nighttime GH pulse. If you tolerate it well, you move to 200 mcg, with advanced users commonly running 300 mcg nightly. The standard schedule is 5 days on and 2 days off each week. Most research cycles run 12–24 weeks, followed by a break period before starting another block.

Safety

What to watch for

Generally safe. Not for active cancer. May cause water retention initially.

Best for

Who benefits most

This is for the peptide user who wants to start intelligently, not aggressively: better recovery, leaner body composition, and more resilient aging support without jumping straight into a stronger stack. It fits the research-minded buyer who values physiologic signaling, clean protocol design, and a gradual entry into GH-axis optimization.

Not for

Who should avoid it

Not for anyone with active cancer, a history of GH-sensitive malignancy, or uncontrolled endocrine disease. Avoid use alongside other GH-axis agents unless the protocol is intentionally designed and monitored.

Build your stack

Sermorelin works best inside a protocol.

Pepzilla matches it with the right companions, dosing, and lifestyle rails for your goals — calibrated in 60 seconds.

Build my stack Browse encyclopedia